Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Vero Cell-Derived H5N1 Influenza Vaccine (Vepacel) in Adults and Elderly
NCT00462215Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Apr 2007
- Primary completion
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of inactivated influenza vaccine, whole virion, vero cell-derived, sponsored by Resilience Government Services. Started Apr 2007; status: completed.
02
Drugs
inactivated influenza vaccine, whole virion, vero cell-derived
Beyond the preview
Go deeper on NCT00462215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462215.